<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>16</Volume>
				<Issue>14</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Pathologic Risk Factors and Oncologic Outcomes in Early-stage Cervical Cancer Patients Treated by Radical Hysterectomy and Pelvic Lymphadenectomy at a Thai University Hospital: A 7 year Retrospective Review</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>5951</FirstPage>
			<LastPage>5956</LastPage>
			<ELocationID EIdType="pii">31353</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;b&gt;Background:&lt;/b&gt; To evaluate the rate of pathologic high-risk factors, intermediate-risk factors, and treatmentoutcomes in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy(RHPL). Materials and &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: Medical records of stage IA-IIA1 cervical cancer patients who underwent RHPLduring the 2006 to 2012 time period and patient follow-up data until December 2013 were reviewed. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: Of331 patients, 52 women (15.7%) had pathologic high-risk factors and 59 women (17.8%) had intermediate-riskfactors without high-risk factors. All studied patients had an initial complete response. At median follow-up timeof 40.9 months (range 1-103.3 months) and mean follow-up time of 43.3±25.3 months, 37 women had diseaserecurrence and 4 women had died of disease. The most common site of recurrence was the pelvis (64.8%). Fiveyearand 10-year disease free survival rates were 96.1% and 91.5%, respectively. Five-year and 10-year overallsurvival rates were 100% and 99.4%, respectively. Independent factors related to recurrence were pelvic nodemetastasis (odds ratio [OR], 2.670; 95%CI, 1.001-7.119), and &gt;1/3 cervical stromal invasion (OR, 3.763; 95%CI,1.483-9.549). &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: The rates of pathologic high-risk and intermediate-risk factors should be consideredand disclosed when counseling patients regarding primary treatment by RHPL. Oncologic outcomes of primarysurgical treatment for early-stage cervical carcinoma were found to be excellent.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Pathologic risk factors</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cervix</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">cervical cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Radical hysterectomy</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_31353_859e337be791b721a87fcb3ffa11ce81.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
